Trials / Completed
CompletedNCT00433225
Efficacy of Topical Ketorolac Versus Placebo for Improving Visual Outcomes Following Multifocal IOL Implantation
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Innovative Medical · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- —
Summary
The purpose of this study was to evaluate the efficacy of ketorolac 0.4% on quality of vision and macula thickening in patients undergoing cataract surgery using the ReStor® multifocal IOL.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Prednisolone Acetate | |
| DRUG | Ketorolac 0.4% | |
| DRUG | Gatifloxacin 0.3% |
Timeline
- First posted
- 2007-02-09
- Last updated
- 2007-09-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00433225. Inclusion in this directory is not an endorsement.